Completed
A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
NCT02279433
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +23 more
- Locations
-
- HonorHealth Research Institute Scottsdale, Arizona, United States
- Chao Family Comprehensive Cancer Center of Orange, California, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Inst. Boston, Massachusetts, United States